Searched for
GENERIC ORAL CONTRACEPTIVES
Lupin gets USFDA nod for generic oral contraceptive pillLupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drosp...
Lupin launches generic oral contraceptive tablets in USThe USFDA had earlier given approval to market a generic version of Janssen Pharmaceuticals, Inc.'s Ortho Tri-Cyclen tablets in the same st...
Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
Lupin gets USFDA nod for generic oral contraceptive tabletsLupin today said it has received US health regulator's final approval to market Blisovi oral contraceptive tablets in different strengths i...
Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
Bayer evaluating options in oral contraceptive patent caseBayer AG said it "disagrees" with a US court ruling that allowed Indian rival Lupin to sell generic version of its oral contraceptive (OC) ...
Oral Contraceptives Booster to Lupin's US businessAs per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.
Favourable ruling for generic Yaz in US court, says LupinDrug major Lupin today said a US court has ruled in its favour paving the way for the company to introduce a generic version of Bayer AG's ...
Lupin gets US nod for 7th oral contraceptiveLupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...
Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...
- Lupin gets USFDA approval for oral contraceptive tablets Kurvelo
Drug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
- Glenmark recalls select lot of oral contraceptive in US
Glenmark Pharmaceuticals today said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgesti...
- Glenmark Pharmaceuticals gets USFDA approval for oral contraceptives
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic two oral contraceptives tab...
- Lupin eyes $150 mn from oral contraceptives in US by FY14
Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin gets USFDA nod for generic oral contraceptive tablets
Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Lupin gains on USFDA nod; Goldman recommends 'Buy'
Shares of drugmaker Lupin rose nearly 2 percent after it received the US regulatory approval on Tuesday to launch oral contraceptive
- Lupin gets FDA approval for oral contraceptive
LPI has been granted final approval by the US FDA for its ANDA to market a generic version of Watson's NOR-QD® tablets.
- AIF Capital to invest $40 mn in Famy Care
AIF Capital, one of the largest Asia-based independent private equity firms, on Wednesday announced that AIF Capital Asia III, LP has inves...